Feasibility of aortic valve assessment with low dose prospectively triggered adaptive systolic (PTAS) cardiac computed tomography angiography

Background: Cardiac computed tomography angiography (CTA) is feasible for aortic valve evaluation, but retrospective gated protocols required high radiation doses for aortic valve assessment. A prospectively triggered adaptive systolic (PTAS) cardiac CT protocol was recently described in arrhythmia using second-generation dual-source CT. In this study, we sought to evaluate the feasibility of PTAS CTA to assess the aortic valve at a low radiation dose. Findings: A retrospective cohort of 29 consecutive patients whom underwent PTAS protocols for clinical indications other than aortic valve assessment and whom also received echocardiography within 2 months of CT, was identified. Images were reviewed for aortic valve morphology (tricuspid/bicuspid/prosthetic) and stenosis (AS) by experienced blinded readers. Accuracy versus echocardiography and radiation doses were assessed. All PTAS coronary CTAs were clinically diagnostic with 0 un-evaluable coronary segments. The accuracy of PTAS for aortic valve morphology was 92.6%, and for exclusion of severe AS was 93.1%. Two exams were un-evaluable for the aortic valve due to inadequate number of phases archived for interpretation. Total radiation dose was a median of 2.8 mSv (interquartile range 1.4–4.4 mSv). Conclusions: PTAS CTA protocols using second-generation dual-source CT for aortic valve evaluation are feasible at low doses. This protocol should be investigated further in larger cohorts

Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates.

PURPOSE: To determine the effectiveness and complication rates of ablation of renal cell carcinoma (RCC) performed with a percutaneous approach versus a surgical approach. MATERIALS AND METHODS: A search performed on PubMed identified series of renal tumor ablations. Keywords searched included radiofrequency (RF), cryoablation , cryosurgery , cryotherapy , ablation , renal , kidney , and RCC . Review articles were excluded from the search of English-language literature from January 1996 through August 2006. Inclusion criteria were (i) more than one case, (ii) use of RF ablation or cryoablation, (iii) effectiveness based on follow-up imaging, and (iv) report of complication rate. Effectiveness was defined by the proportion of tumors without residual enhancement after one treatment session (ie, primary effectiveness) or after repeated treatments (ie, secondary effectiveness). Major complications were defined as events with substantial morbidity, disability, or increasing level of care. Metaanalysis was performed on primary effectiveness, secondary effectiveness, and major complication rates with a random-effects model. Differences were considered significant if the 95% CIs did not overlap. RESULTS: Forty-six series (28 percutaneous, 18 surgical) met all inclusion criteria. The primary effectiveness rate for the percutaneous group (87%) was significantly lower than that in the surgical group (94%; P \u3c .05). The secondary effectiveness rate in the percutaneous treatment group (92%) was not significantly different from that in the surgical treatment group (95%; P \u3e .05). The major complication rate in the percutaneous treatment group (3%) was significantly lower than that in the surgical treatment group (7%; P \u3c .05). CONCLUSIONS: Based on a metaanalysis, when ablating renal tumors, a percutaneous approach was safer than an open or laparoscopic approach and was equally effective. However, more than one procedure was needed to treat the tumor completely

Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices

Abstract Autosomal genetic analyses of blood lipids have yielded key insights for coronary heart disease (CHD). However, X chromosome genetic variation is understudied for blood lipids in large sample sizes. We now analyze genetic and blood lipid data in a high-coverage whole X chromosome sequencing study of 65,322 multi-ancestry participants and perform replication among 456,893 European participants. Common alleles on chromosome Xq23 are strongly associated with reduced total cholesterol, LDL cholesterol, and triglycerides (min P = 8.5 × 10−72), with similar effects for males and females. Chromosome Xq23 lipid-lowering alleles are associated with reduced odds for CHD among 42,545 cases and 591,247 controls (P = 1.7 × 10−4), and reduced odds for diabetes mellitus type 2 among 54,095 cases and 573,885 controls (P = 1.4 × 10−5). Although we observe an association with increased BMI, waist-to-hip ratio adjusted for BMI is reduced, bioimpedance analyses indicate increased gluteofemoral fat, and abdominal MRI analyses indicate reduced visceral adiposity. Co-localization analyses strongly correlate increased CHRDL1 gene expression, particularly in adipose tissue, with reduced concentrations of blood lipids